Ravva P - Search Results

1

Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation.

Ravva P, Gastonguay MR, French JL, Tensfeldt TG, Faessel HM. Ravva P, et al. Clin Pharmacol Ther. 2010 Mar;87(3):336-44. doi: 10.1038/clpt.2009.282. Epub 2010 Jan 27. Clin Pharmacol Ther. 2010. PMID: 20107434 Clinical Trial.

2

Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Faessel H, Ravva P, Williams K. Faessel H, et al. Among authors: ravva p. Clin Ther. 2009 Jan;31(1):177-89. doi: 10.1016/j.clinthera.2009.01.003. Clin Ther. 2009. PMID: 19243716 Clinical Trial.

3

Population pharmacokinetic analysis of varenicline in adult smokers.

Ravva P, Gastonguay MR, Tensfeldt TG, Faessel HM. Ravva P, et al. Br J Clin Pharmacol. 2009 Nov;68(5):669-81. doi: 10.1111/j.1365-2125.2009.03520.x. Br J Clin Pharmacol. 2009. PMID: 19916991 Free PMC article.

4

A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation.

Faessel HM, Obach RS, Rollema H, Ravva P, Williams KE, Burstein AH. Faessel HM, et al. Among authors: ravva p. Clin Pharmacokinet. 2010 Dec;49(12):799-816. doi: 10.2165/11537850-000000000-00000. Clin Pharmacokinet. 2010. PMID: 21053991 Review.

5

Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers.

Ravva P, Gastonguay MR, Faessel HM, Lee TC, Niaura R. Ravva P, et al. Nicotine Tob Res. 2015 Jan;17(1):106-13. doi: 10.1093/ntr/ntu154. Epub 2014 Aug 21. Nicotine Tob Res. 2015. PMID: 25145377 Free PMC article. Clinical Trial.

6

Missing data in model-based pharmacometric applications: points to consider.

Gastonguay MR, French JL, Heitjan DF, Rogers JA, Ahn JE, Ravva P. Gastonguay MR, et al. Among authors: ravva p. J Clin Pharmacol. 2010 Sep;50(9 Suppl):63S-74S. doi: 10.1177/0091270010378409. J Clin Pharmacol. 2010. PMID: 20881220 No abstract available.

7

A linearization approach for the model-based analysis of combined aggregate and individual patient data.

Ravva P, Karlsson MO, French JL. Ravva P, et al. Stat Med. 2014 Apr 30;33(9):1460-76. doi: 10.1002/sim.6045. Epub 2014 Feb 2. Stat Med. 2014. PMID: 24488864

8

Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and Infants.

Gibiansky L, Ravva P, Parrott NJ, Bhardwaj R, Zwanziger E, Grimsey P, Clinch B, Sturm S. Gibiansky L, et al. Among authors: ravva p. Clin Pharmacol Ther. 2020 Jul;108(1):126-135. doi: 10.1002/cpt.1791. Epub 2020 Feb 26. Clin Pharmacol Ther. 2020. PMID: 31957010 Free PMC article.

9

Integrated population pharmacokinetic analysis of voriconazole in children, adolescents, and adults.

Friberg LE, Ravva P, Karlsson MO, Liu P. Friberg LE, et al. Among authors: ravva p. Antimicrob Agents Chemother. 2012 Jun;56(6):3032-42. doi: 10.1128/AAC.05761-11. Epub 2012 Mar 19. Antimicrob Agents Chemother. 2012. PMID: 22430956 Free PMC article. Clinical Trial.

10

A continuous-time multistate Markov model to describe the occurrence and severity of diarrhea events in metastatic breast cancer patients treated with lumretuzumab in combination with pertuzumab and paclitaxel.

Xu C, Ravva P, Dang JS, Laurent J, Adessi C, McIntyre C, Meneses-Lorente G, Mercier F. Xu C, et al. Among authors: ravva p. Cancer Chemother Pharmacol. 2018 Sep;82(3):395-406. doi: 10.1007/s00280-018-3621-9. Epub 2018 Jun 18. Cancer Chemother Pharmacol. 2018. PMID: 29915982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters